Unlike naive T cells, effector T cells can be activated by either T cell receptor signal or costimulatory signal alone and therefore the absence of costimulatory molecules on tissue cells cannot explain the tolerance mechanism at the effector phase. Here we report that PD-L1, the ligand for the immunoinhibitory receptor PD-1, was expressed on vascular endothelium in peripheral tissues. Liver nonparenchymal cells including sinusoidal endothelial cells and Kupffer cells constitutively expressed PD-L1 and inhibited proliferation and cell division of activated T cells expressing PD-1. The absence of PD-1 induced proliferation of effector T cells in the adenovirus-infected liver and resulted in rapid clearance of the virus. These results indicate that PD-1 plays an important role in T cell tolerance at the effector phase and the blockade of the PD-1 pathway can augment antiviral immunity.
Skip Nav Destination
Article navigation
7 July 2003
Article|
July 07 2003
PD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver
In Special Collection:
2018 Nobel Prize Collection
Yoshiko Iwai,
Yoshiko Iwai
Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
Search for other works by this author on:
Seigo Terawaki,
Seigo Terawaki
Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
Search for other works by this author on:
Masaya Ikegawa,
Masaya Ikegawa
Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
Search for other works by this author on:
Taku Okazaki,
Taku Okazaki
Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
Search for other works by this author on:
Tasuku Honjo
Tasuku Honjo
Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
Search for other works by this author on:
Yoshiko Iwai
Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
Seigo Terawaki
Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
Masaya Ikegawa
Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
Taku Okazaki
Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
Tasuku Honjo
Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
Address correspondence to Tasuku Honjo, Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan. Phone: 81-75-753-4371; Fax: 81-75-753-4388; E-mail: [email protected]
*
Abbreviations used in this paper: CTLA-4, cytotoxic T lymphocyte antigen-4; EC, endothelial cell; LNPC, liver nonparenchymal cell; LSEC, liver sinusoidal endothelial cell.
Received:
December 30 2002
Revision Received:
April 02 2003
Accepted:
April 15 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 198 (1): 39–50.
Article history
Received:
December 30 2002
Revision Received:
April 02 2003
Accepted:
April 15 2003
Citation
Yoshiko Iwai, Seigo Terawaki, Masaya Ikegawa, Taku Okazaki, Tasuku Honjo; PD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver . J Exp Med 7 July 2003; 198 (1): 39–50. doi: https://doi.org/10.1084/jem.20022235
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement